The same genomic position of KMT2C (7q36.1) is shared with the EZH2 gene, the histone methyltransferase enhancer of the Zeste Homolog 2, whose mutations are observed in up to 9% of de novo and secondary AML [20]. Here, PRDM9 is linked to acute myeloid leukemia.